Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

Ansell, S M; Stenson, M; Habermann, T M; Jelinek, D F; Witzig, T E

Ansell, S M; Stenson, M; Habermann, T M; Jelinek, D F; Witzig, T E.

Affiliation

Ansell SM; Division of Hematology and Internal Medicine, Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.

J Clin Oncol ; 19(3): 720-6, 2001 Feb 01.

Article in En | MEDLINE | ID: mdl-11157023

Subject(s)

CD4-Positive T-Lymphocytes/immunology; Lymphoma, B-Cell/immunology; Lymphoma, Large B-Cell, Diffuse/immunology; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biopsy; Disease-Free Survival; Female; Flow Cytometry; Humans; Immunophenotyping; Lymphocyte Activation/immunology; Lymphocytes, Tumor-Infiltrating/immunology; Lymphoma, B-Cell/drug therapy; Lymphoma, B-Cell/pathology; Lymphoma, Large B-Cell, Diffuse/drug therapy; Lymphoma, Large B-Cell, Diffuse/pathology; Male; Middle Aged; Prospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Lymphoma, B-Cell / Lymphoma, Large B-Cell, Diffuse Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links